Navigation Links
Meeting to examine FDA requirements for manufacturing PET radiopharmaceuticals
Date:3/26/2009

Reston, VASNM and the International Partnership for Critical Markers of Disease (CMOD) are co-hosting an in-depth meeting on Friday, May 1, 2009, examining FDA requirements for manufacturing positron emission tomography (PET) radiopharmaceuticals. The meeting, which takes place at the Natcher Auditorium, National Institutes of Health, Bethesda, Md., is scheduled to begin at 6:10 p.m. and conclude at 9:45 p.m.

"We are pleased to collaborate with the International Partnership for Critical Markers of Disease on this important meeting," said Michael Graham, M.D., Ph.D., SNM president-elect and director of nuclear medicine at the University of Iowa Carver College of Medicine. "New developments in molecular imaging technologies are dramatically improving the ways in which cardiovascular disease, neurological disorders and cancer are diagnosed and treated. It is essential that we work together as a scientific community to facilitate personalized medicine through the development of advanced imaging techniques and new radiopharmaceuticals that will enable physicians to determine early on the precise location of disease, and evaluate and monitor the effectiveness of therapy."

"SNM and CMOD share a common interest in accelerating scientific research to bring the best in health care to patients today," said Thrse Heinonen, DVM, executive director of the International Partnership for Critical Markers of Disease. "With an active interest in the evaluation of potential cardiovascular biomarkers and their appropriate application in clinical trials, a partnership with SNM is a natural fit."

Don Black, head of research and development at GE Healthcare's Medical Diagnostics, Dwaine Rieves, director of medical imaging at the U.S. Food and Drug Administration, and Michael Graham from SNM will kick off the special May 1 evening session. Dennis Swanson, University of Pittsburgh, and Sally Schwarz, Washington University, will survey the regulation history of
'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
2. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
3. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
4. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
5. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
6. SCAI and ACC announce new interventional cardiology meeting
7. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
8. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
9. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
10. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
11. UNCOVERING THE TRUTH - A Town Hall Meeting on Mental Health Parity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... SpineFrontier, a Less Exposure Surgery (LES) technology company, ... market their new sacroiliac joint fusion screw, the SIJ ... and is compatible with both lateral and alternate posterior ... researched and refined by SpineFrontier, the first company to ... conjunction with a sacroiliac joint fusion system like this. ...
(Date:5/2/2015)... As one of only 30 Illinois companies to ... Achievement and Recognition Program (SHARP) certification, Essentra Specialty ... Illinois Department of Labor to host this special event. ... by the Occupational Safety and Health Administration’s (“OSHA”) Onsite ... meet or exceed all of the necessary regulations and ...
(Date:5/2/2015)... “ ActOn ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... organizations to make a difference. , In this material world, ... that aren’t about money, which is why those things should ...
(Date:5/2/2015)... We are pleased to announce the Sun ... one of the Top Workplaces of 2015. , The ... field for their ethics and standards of excellence. The ... their educational efforts. The Delray Recovery Center prides itself ... purpose – to help individuals heal from the disease ...
(Date:5/2/2015)... May 02, 2015 Kare Visits LLC. launched ... for busy caregivers. Kare Visits offers relief for caregivers ... living facilities. According to the Caregiver Action Network, ... average of 20 hours a week caring for an elderly ... cost to hire a nurse, a caregiver is now empowered ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2
... Britain’s biggest supermarket, TESCO, was in public glare for the wrong ... of land and for not being party to a movement that ... Standards Agency got after Tesco, soon after the latter rejected the ... has made profits of over ?2 billion last year and a ...
... in the 'Pongala Mahotsavam,' festival at the Attukal Bhagavathy temple, ... began on March 5 and will culminate as a grand ... a very auspicious and important festival of this temple, which ... The devotees make a dish of rice and jaggery as ...
... decided to provide health insurance to approximately 80,000 employers ... funding for the insurance would be contributed by the ... ,Mike Huckabee of the Arkansas Government has ... employees. This move is anticipated to yield considerable revenue ...
... resentment against the NHS proposal to allow nurses to ... the move as being equivalent to entrusting airhostesses // ... the British Medical Association (BMA) has been urged to ... to conduct operations on patients. More than 130 doctors ...
... China have identified the deadly H5N1 virus in geese, ducks ... sparking fears of bird flu pandemic//. ,It has ... flu virus. This however is the first time that large-scale ... chickens. Infected chickens usually die within 24 hours of the ...
... West Bengal Chief Minister Buddhadeb Bhattacharya has pledged to ... ,The general secretary of Ganadarpan, Brojo Roy said ... in this cause." Ganadarpan is an NGO with which ... ,Bhattacharya joins other communist leaders like Jyoti Basu, Somnath ...
Cached Medicine News:Health News:Doctors Protest Against Allowing Nurses To Perform Minor Surgeries 2Health News:Healthy, Bird Flu Infected Chickens In Chinese Markets 2
(Date:5/1/2015)... 2015  CytRx Corporation (CYTR), a biopharmaceutical research ... financial results for the three months ended March ... accomplishments and upcoming milestones for its clinical development ... the early months of 2015, including the announcement ... aldoxorubicin in patients with soft tissue sarcoma, and ...
(Date:5/1/2015)... , May 1, 2015 The Institute for ... health literacy award winners. The IHA Health Literacy Awards ... an impact on the practice of educating or empowering ... IHA gives awards in three categories: innovative programs, published ... Health Literacy Hero award. In the area ...
(Date:5/1/2015)... -- Pharmacyclics, Inc. (the "Company") (NASDAQ: PCYC ) ... 31, 2015, as well as general business updates. Due ... will be held. Key Highlights , ... increased to $206 million from $119 million for the ... ® (ibrutinib) net product revenue of $247 million ...
Breaking Medicine Technology:CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11Institute for Healthcare Advancement Announces 2015 Award Winners 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25
... to Show That Extended,Thromboprophylaxis Reduces VTE Risk ... 44% , PARIS, July 8, 2007 /PRNewswire-FirstCall/ ... (EXtended CLinical,prophylaxis in Acutely Ill Medical patients) ... in acutely ill medical patients,with reduced mobility ...
... Positive Phase IIa Clinical,Trial Results, First clinical ... in AM-Pharma's Pipeline , BUNNIK, The Netherlands, ... novel therapeutics to treat,infectious and inflammatory diseases, ... Phase IIa Alkaline Phosphatase (AP) trial,for patients ...
Cached Medicine Technology:New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 2New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 3New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 4New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 5New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 6AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
... Knife with BD Xstar Blade includes a ... the blade in prodedure and handling. ... a grind-less process for manufacturing surgical blades. ... and consistency. The arch style, single-bevel ...
Consists of the print and PDA versions of Harrison's Manual of Medicine 15th Edition. Provides high-end medical content via PDA....
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists....
... The SphygmoCor Mx Central Blood ... of the SphygmoCor Px system by ... aortic pressure waveform., ,Key cardiovascular parameters ... trended. These parameters include:, Central ...
Medicine Products: